BioSpace News Archive

Amenorrhea Market: Rise in number of cases of amenorrhea to drive the market

Albany NY, United States: Amenorrhea is a situation where menstruation does not occur in women of child bearing age.

April 6, 2022
·
6 min read
Global Pyrazinamide Market Growth Rate and Demand Opportunity Analysis – (2020 – 2030)

The pyrazinamide market is anticipated to gain extensive growth during the assessment period of 2020-2030 on the back of the rising prevalence of tuberculosis across the world.

April 6, 2022
·
5 min read
Polyp Trap Devices Market: Europe is anticipated to account for a significant share of the global market

Albany NY, United States: Polyp is an abnormal growth on the mucus membrane. These are small flat mushroom-like growths that sometimes have stalk which connects them to mucus tissue.

April 6, 2022
·
6 min read
Over-the-Counter Pain Medication Market is estimated to attain a valuation of US$ 27.7 Billion by 2028 - Comprehensive Research Report by FMI

DUBAI, United Arab Emirates, The OTC Pain Medication Market surpassed US$ 18 billion in 2018, with growth influenced by changing perceptions on generic pharmaceutical drugs, according to a recent study published by Future Market Insights.

April 6, 2022
·
5 min read
Ophthalmic Anti-infective Market: Increase in incidence of eye infection to drive the market

Albany NY, United States: Growing risk of infection is associated with the rise in number of ophthalmic surgical operations.

April 6, 2022
·
5 min read
Myeloproliferative Disorders Drugs Market Global Demand and Growth Opportunity – Industry Analysis Report

The demand within the global market for myeloproliferative disorder drugs has been expanding on account of key advancements in the domain of oncology treatments.

April 6, 2022
·
5 min read
Tissue Heart Valves Market: High Prevalence of Heart Valve Diseases to Drive the Market

Albany NY, United States: Tissue or biological heart valve is made from animal tissue, such as porcine or bovine, as it is similar to human tissue.

April 6, 2022
·
5 min read
Biotech Bay

Innovent Announces the Approval of Pemazyre® (pemigatinib) by the NMPA for the Treatment of Adults with Locally Advanced or Metastatic Cholangiocarcinoma

Innovent Biologics, Inc. announced that the National Medical Products Administration (NMPA) has approved Pemazyre.

April 6, 2022
·
9 min read
Addex Expands Pipeline with Selective M4 Positive Allosteric Modulator Program for the Treatment of Schizophrenia & Other Psychotic Disorders

Addex Therapeutics announced that it has moved a selective and potent M4 muscarinic receptor positive allosteric modulator program into lead optimization.

April 6, 2022
·
5 min read
Business

ViGeneron signs gene therapy strategic collaboration and option agreement with Regeneron for one inherited retinal disease target

ViGeneron GmbH, a next-generation gene therapy company, announced a target-specific strategic collaboration and option agreement with Regeneron Pharmaceuticals Inc. to develop and commercialize a gene therapy product based on ViGeneron’s novel engineered recombinant adeno-associated virus vectors to treat an inherited retinal disease.

April 6, 2022
·
3 min read